Astrazeneca Share Discussion Threads

[alphorn] 01/11/2024 11:09

This issue is quite strange - what was this data? Remembering that if clinical trial data it is presented in the approval process from many sites around the globe.
There must be more to come.

[alphorn] 31/10/2024 11:32

Hi Dud - no idea what it is about.

Maybe this:
.............part of a widespread crackdown in China on healthcare corruption and how patient information is disseminated outside of the country.

Earlier this year, five other Chinese employees in AZ's oncology division were detained as part of an investigation into alleged breaches of data privacy laws.

[dudishes] 31/10/2024 10:24

Tks Al!

Was rejoicing 300pts+ up, stopped out at 105pts down.

Blickin boats/fishing eh?

[suetballs] 28/10/2024 14:33

Yep - can I get treatment on the nhs for broad shoulders!
Suet

[geckotheglorious] 28/10/2024 14:09

Suet

From anyone with "something"

[suetballs] 28/10/2024 10:31

Yes but where will Labour get the dosh from?
Suet

[alphorn] 28/10/2024 10:13

Underwritten by the UK government when approved if I remember:

[dudishes] 21/10/2024 13:45

Above post corrected, numbers were in wrong order.

[dudishes] 16/10/2024 23:07

A rare long that counts, 234pts and counting!

[thamestrader] 08/10/2024 10:33

i.e., they left their price target unchanged.

[philanderer] 08/10/2024 10:10

Goldman Sachs raises AstraZeneca price target to 16,046 (15,914) pence - 'buy'

[dudishes] 07/10/2024 08:23

Thanks Waldron,

Exciting times on most fronts.

Back in 11726.

Confess, was one of my very long term holdings, thought it had peaked £10ish?

Day trading to doddery trading?

[waldron] 07/10/2024 08:03

AstraZeneca plc

77.47 USD −0.46 (0.59%)

Oct 4, 16:00 EDT

77.32 USD ‎11:10

Open
77.08

High
77.55

Low
76.90

Mkt cap
241.98B

P/E ratio
37.56

Div yield
1.92%

CDP score
A-

52-wk high
87.67

52-wk low
60.48

[philanderer] 13/9/2024 18:46

Non-Exec Chairman of the Board.

Buy today 2,000 @ £117.927465 = £235,854.93p

[philanderer] 13/9/2024 09:20

Downgraded this morning. - leaked yesterday ?


Deutsche Bank cuts AstraZeneca to 'sell' (hold) - price target 10,500 (11,000) pence

[philanderer] 13/9/2024 08:55

Chart support around 11000p hopefully

[smcni1968] 12/9/2024 20:02

Uncertainty about whether their cancer drug will be approved

[philanderer] 12/9/2024 17:15

China weighing on the share price maybe ?

[philanderer] 11/9/2024 23:09

On Wednesday, BMO Capital maintained a positive outlook on shares of AstraZeneca (NASDAQ:AZN) shares, reiterating an Outperform rating and a price target of $89.00. The firm's stance comes in the wake of AstraZeneca's investor event, which took place yesterday, following the company's presentations at the World Lung Conference.





Erste Group analyst Hans Engel upgraded AstraZeneca to Buy from Hold citing strong sales growth for the company’s oncology products. AstraZeneca’s operating margin and sales growth are above the sector average and its operating margin shows an upward trend, the analyst tells investors in a research note. The firm says the company’s profits will grow at an above-average rate this year and also in 2025.

[beckers2008] 11/9/2024 09:22

Maybe time to top up?
Long term, maybe a wise move?